| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 14k | $8.13 | $113.4k | | 06/08/2023 |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | Common Stock | 2.3k | $0.00 | $0 | | 06/08/2023 |
| 07/15/2022 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $16.64 | $266.2k | | 07/15/2022 |
| 05/16/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 5k | $13.62 | $68.1k | | 05/13/2022 |
| 05/13/2022 | Evolus, Inc. | EOLS | Sale | Common Stock | 5.3k | $13.10 | $69.6k | | 05/13/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 22.7k | $5.46 | $124.1k | | 01/24/2022 |
| 01/24/2022 | Evolus, Inc. | EOLS | Grant | Common Stock | 15.6k | $0.00 | $0 | | 01/24/2022 |
| 10/05/2021 | Strongbridge Biopharma plc | SBBP | Disposition | Ordinary Shares | 78.1k | $0.00 | $0 | | 10/05/2021 |
| 10/01/2021 | Strongbridge Biopharma plc | SBBP | Payment of Exercise | Ordinary Shares | 17.8k | $2.06 | $36.6k | | 10/01/2021 |
| 06/10/2021 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $37.53 | $600.5k | | 06/10/2021 |
| 05/18/2021 | Strongbridge Biopharma plc | SBBP | Grant | Ordinary Shares | 40k | $0.00 | $0 | | 05/18/2021 |
| 02/05/2021 | Evolus, Inc. | EOLS | Grant | Common Stock | 19.3k | $0.00 | $0 | | 02/05/2021 |
| 01/19/2021 | Y-mAbs Therapeutics, Inc. | YMAB | Sale | Common Stock | 2k | $46.52 | $93k | | 01/19/2021 |
| 01/19/2021 | Y-mAbs Therapeutics, Inc. | YMAB | Exercise | | 2k | $11.16 | $22.3k | | 01/19/2021 |
| 11/18/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Sale | | 2k | $45.77 | $91.5k | | 11/18/2020 |
| 11/18/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Exercise | | 2k | $11.16 | $22.3k | | 11/18/2020 |
| 11/03/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Exercise | | 4k | $11.16 | $44.6k | | 11/03/2020 |
| 11/03/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Sale | | 4k | $45.00 | $180k | | 11/03/2020 |
| 09/24/2020 | Strongbridge Biopharma plc | SBBP | Purchase | Ordinary Shares | 8k | $2.13 | $17k | | 09/24/2020 |
| 09/03/2020 | Strongbridge Biopharma plc | SBBP | Payment of Exercise | Ordinary Shares | 23.1k | $3.61 | $83.4k | | 09/03/2020 |
| 06/23/2020 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $48.67 | $778.7k | | 06/23/2020 |
| 05/14/2020 | Strongbridge Biopharma plc | SBBP | Grant | Ordinary Shares | 40k | $0.00 | $0 | | 05/14/2020 |
| 01/23/2020 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 23.5k | $10.19 | $239k | | 01/23/2020 |
| 11/22/2019 | STRATA Skin Sciences, Inc. | SSKN | Grant | | 18.3k | $0.00 | $0 | | 11/22/2019 |
| 09/03/2019 | Strongbridge Biopharma plc | SBBP | Grant | Ordinary Shares | 50k | $0.00 | $0 | | 09/03/2019 |
| 06/13/2019 | Evolus, Inc. | EOLS | Purchase | Common Stock | 2k | $13.65 | $27.3k | | 06/13/2019 |
| 06/12/2019 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $21.45 | $343.2k | | 06/12/2019 |
| 06/11/2019 | CEMPRA, INC. | MLNT | Grant | Melinta Restricted Stock Units | 30k | $0.00 | $0 | | 06/11/2019 |
| 01/23/2019 | Evolus, Inc. | EOLS | Grant | Stock Option (Right to Buy) | 14.5k | $16.19 | $234.8k | | 01/23/2019 |
| 12/14/2018 | Evolus, Inc. | EOLS | Purchase | Common Stock | 3k | $12.77 | $38.3k | | 12/14/2018 |
| 06/15/2018 | Ocugen, Inc. | HSGX | Grant | Stock Option (Right to Buy) | 25k | $2.97 | $74.2k | | 06/15/2018 |
| 06/12/2018 | CEMPRA, INC. | MLNT | Grant | Stock Option (right to buy) | 9.1k | $7.45 | $67.8k | | 06/12/2018 |
| 06/12/2018 | CEMPRA, INC. | MLNT | Grant | Stock Option (right to buy) | 25k | $7.45 | $186.2k | | 06/12/2018 |
| 06/08/2018 | STRATA Skin Sciences, Inc. | SSKN | Grant | | 31.4k | $0.00 | $0 | | 06/08/2018 |
| 06/08/2018 | STRATA Skin Sciences, Inc. | SSKN | Grant | STRATA Restricted Stock Units | 26.6k | $2.07 | $55k | | 06/08/2018 |
|